1. Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment
   Maren Schoepp et al, 2017, Cancers CrossRef
2. MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers
   Dorothea Portius et al, 2017, PPAR Research CrossRef
3. Mechanistic roles of microRNAs in hepatocarcinogenesis: A study of thioacetamide with multiple doses and time-points of rats
   Harsh Dweep et al, 2017, Sci Rep CrossRef
4. Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate
   Emuejevoke Olokpa et al, 2017, PPAR Research CrossRef
5. Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
   Ying Wan et al, 2017, The American Journal of Pathology CrossRef
6. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of miR-34a and miR-29c in hepatic stellate cells
   Qing Liu et al, 2017, Biosci. Rep. CrossRef
7. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
   Florian Schueller et al, 2018, IJMS CrossRef
8. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
   Mio Kitano et al, 2016, JCM CrossRef
9. Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis
   Yoshifumi Iwagami et al, 2018, J Cell Mol Med CrossRef
10. PPAR-γ: Its ligand and its regulation by microRNAs
    Parvaneh Seiri et al, 2019, J Cell Biochem CrossRef
11. miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.
    S-L Tung et al, 2017, Oncogenesis CrossRef
12. Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study
    Stefano Di Carlo et al, 2016, PLoS ONE CrossRef
13. Sulfated glycosaminoglycans and non-classically secreted proteins, basic FGF and epimorphin, coordinately regulate TGF-β-induced cell behaviors of human scar dermal fibroblasts
    Tomoatsu Horigome et al, 2017, Journal of Dermatological Science CrossRef
14. MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice
    Jae-Sang Hong et al, 2017, Bioscience, Biotechnology, and Biochemistry CrossRef
15. The roles of microRNA families in hepatic fibrosis
    Xue-Ping Jiang et al, 2017, Cell Biosci CrossRef
16. The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation
    Sara Carpi et al, 2019, Nutrients CrossRef
17. Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD.
    Ghideon Ezaz et al, 2020, Hepatol Commun CrossRef
18. Peroxisome proliferator-activated receptorγinhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis
    Le Tao et al, 2020, Life Sciences CrossRef
19. Role of ncRNAs in modulation of liver fibrosis by extracellular vesicles
    Giulia Chiabotto et al, 2020, ExRNA CrossRef
20. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease
    Guillermo Nahúm López-Sánchez et al, 2020, Annals of Hepatology CrossRef
21. Non-coding RNA crosstalk with nuclear receptors in liver disease
    Jianguo Wu et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
22. Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation
    Jian Zhang et al, 2021, IJMS CrossRef
23. Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis.
    Pasquale Piccolo et al, 2021, Proc Natl Acad Sci U S A CrossRef
24. Peroxisome Proliferator-Activated Receptors (PPAR), fatty acids and microRNAs: Implications in women delivering low birth weight babies.
    Deepali P. Sundrani et al, 2021, Systems Biology in Reproductive Medicine CrossRef
25. PPAR control of metabolism and cardiovascular functions
    David Montaigne et al, 2021, Nat Rev Cardiol CrossRef
26. The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
    Jingjing Li et al, 2021, DDDT CrossRef
27. Roles of nuclear receptors in hepatic stellate cells
    Shiyun Pu et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef
28. Toward Personalized Medicine in Radiotherapy of Hepatocellular Carcinoma: Emerging Radiomic Biomarker Candidates of Response and Toxicity
    Carolina De la Pinta, 2021, OMICS: A Journal of Integrative Biology CrossRef
29. Therapeutic Potential of MicroRNAs and Their Nanoparticle-based Delivery in the Treatment of Liver Fibrosis
    Jieun Kim et al, 2022 CrossRef
30. MicroRNA-34a: A Novel Therapeutic Target in Fibrosis
    Min Zhao et al, 2022, Front. Physiol. CrossRef
31. Serum non‐coding RNAs for diagnosis and stage of liver fibrosis
    Chao Liu et al, 2022, Clinical Laboratory Analysis CrossRef
32. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
    Mette Yde Hochreuter et al, 2022, Molecular Metabolism CrossRef
33. Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy
    Hong Li et al, 2022, Genes & Diseases CrossRef
34. Sex-specific analysis of microRNA profiles in HBV-associated cirrhosis by small RNA-sequencing.
    Kristy Kwan-Shuen Chan et al, 2022, Hepatol Commun CrossRef
35. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease
    Mohamed Zaiou, 2023, Cells CrossRef
36. Diagnostic potential of serum miR-532-3p as a circulating biomarker for experimental intrinsic drug-induced liver injury by acetaminophen and cisplatin in rats
    Da-Bin Hwang et al, 2023, Food and Chemical Toxicology CrossRef
37. Treating NASH by targeting peroxisome proliferator-activated receptors
    Bart Staels et al, 2023, Journal of Hepatology CrossRef
38. Exploring a New Perspective on Treating Non-Alcoholic Fatty Liver Disease Based on Peroxisome Proliferator-Activated Receptor
    永娇 谭, 2024, ACM CrossRef
39. miR-34a is a tumor suppressor in zebrafish and its expression levels impact metabolism, hematopoiesis and DNA damage
    Sergey V. Prykhozhij et al, 2024, PLoS Genet CrossRef
40. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis.
    Paola Dongiovanni et al, 2018, Int J Mol Sci CrossRef
41. PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells
    Meijian Zhang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
42. Novel intervention for alcohol-associated liver disease
    Fei-Qiong Gao et al, 2024, World J Gastroenterol CrossRef
43. MicroRNA-34a and promoter methylation contribute to peroxisome proliferator-activated receptor gamma gene expression in patients with type 2 diabetes
    Mona Moghadasi et al, 2024, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
44. Non-coding RNAs involved in the regulation of signaling pathways as possible markers of non-alcoholic fatty liver disease progression
    L. I. Topchieva et al, 2024, Izvestiâ Akademii nauk. Rossijskaâ akademiâ nauk. Seriâ biologičeskaâ CrossRef
45. Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?
    Zahid Hussain, 2025, Explor Dig Dis CrossRef